Company: LBRX
Filing Date: 2025-09-08
Form Type: S-1/A
Source: 0001193125-25-197877
Chunk: 294

Company: LB PHARMACEUTICALS INC
Filing Date: 2025-09-08
Form: S-1/A
Chunk 294
---
 the number of shares of our common stock reserved for issuance under our 2025 Plan will automatically increase on January 1 of each calendar year, starting on
January 1, 2026 (assuming the 2025 Plan becomes effective in 2025) through January 1, 2035, in an amount equal to 5% of the total number of shares of our capital stock on a fully diluted basis on the last day of the calendar month before
the date of each automatic increase, or a lesser number of shares determined by our board of directors. The maximum number of shares of our common stock that may be issued on the exercise of incentive stock options under our 2025 Plan is 8,722,005.

In September 2025, our board of directors approved the grant of stock options to (i) current executive officers and employees, effective
upon the pricing of this offering, to purchase a number of shares of common stock such that their beneficial ownership of our total outstanding shares of capital stock as of the pricing date of this offering, on a fully diluted basis after giving
effect to this offering, will be equal to approximately 7.10% and 0.50%, respectively, and (ii) each of our non-employee directors, effective upon the pricing of this offering, to

198

purchase a number of shares that will be equal to 0.10% of our total outstanding shares of capital stock as of the pricing of this offering after giving effect to this offering. These options will have an exercise price equal to the initial public price per share of this offering. Shares subject to stock awards granted under our 2025 Plan that expire or terminate without being exercised in full, or that are paid out in cash rather than in shares, do not reduce the number of shares available for issuance under our 2025 Plan. Additionally, shares become available for future grant under our 2025 Plan if they were issued under stock awards under our 2025 Plan if we repurchase them or they are forfeited. This includes shares used to pay the exercise price of a stock award or to satisfy the tax withholding obligations related to a stock award. Plan Administration. Our board of directors, or a duly authorized committee of our board of directors, will administer our 2025 Plan. Our board of directors may also delegate to one or more persons or bodies the authority to do one or more of the following (i) designate recipients (other than officers) of specified stock awards provided that no person or body